Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Virtual consultation with doctor
The Oxford Sarcoma Service introduced virtual consultations with patients during the pandemic

During the COVID-19 pandemic, unprecedented strain was placed on healthcare systems across the globe. Many patients saw elective surgeries and non-urgent appointments cancelled but essential services like cancer needed to continue to prevent disease progression and reduce mortality.

The Oxford Sarcoma Service at the Nuffield Orthopaedic Centre (one of five nationally approved centres in England for the treatment of rare bone tumours and sarcomas) saw itself urgently needing to reorganise its structure of cancer care.

To ensure continuation of its services whilst minimising transmission among its patients the Oxford Sarcoma Service was re-structured based on the guidelines issued by the National Health Service (NHS) and the British Orthopaedic Oncology Society (BOOS).

A number of changes were implemented without compromising on delivery of a high standard of care to patients, and its experiences have been published in The Journal of Clinical Orthopaedics and Trauma to serve as a guide to similar units managing bone and soft tissue tumours.

The full story is available on the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences website

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.